India Today on MSN: Younger Indians without diabetes lose weight faster on GLP-1 shots TUCSON, Ariz. (KGUN) — Diabetics have many options nowadays for their treatment plans. Afrezza is FDA-approved for adults with type 1 or type 2 diabetes as a fast-acting, mealtime insulin, but it ...

Context Explanation

The Sun: Breakthrough one-off jab could permanently CURE type 1 diabetes replacing daily meds for millions A GROUNDBREAKING new jab could soon “cure” type 1 diabetes, ending the need for insulin injections. Scientists believe the one-off treatment may help the body itself control blood ... Breakthrough one-off jab could permanently CURE type 1 diabetes replacing daily meds for millions A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The study was led by Assistant Professor Shady Farah of the Faculty of Chemical ...

Insight Material

As GLP-1-based drugs gain ground in India, age, diabetes status, and drug choice could shape who benefits most – and how quickly results appear. Seeking Alpha: From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes